RDNT
RadNet, Inc.
Diagnostics & Research · Healthcare · United States
77.31
close · 2026-08-13
value
29
cheaper than peers29
quality
37
stronger fundamentals37
ranked against
Diagnostics & Research
value
quality
28 peers
Value inputs
| measure | company | vs peers |
| price to sales | 2.83× | 69 |
| price to book | 5.62× | 52 |
| EV to EBITDA | 29.43× | 21 |
| forward P/E | 87.19× | 3 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| revenue growth | 22.1% | 77 |
| return on equity | 1.8% | 44 |
| operating margin | -2.8% | 43 |
| debt to equity | 143.0% | 17 |
4 of 4 measures available
Facts
| market cap | $6B |
| free cash flow | $190.5M |
| employees | 11,000 |
| first trade | 1997-01-03 |
| next earnings | 2026-08-09 |
| fundamentals updated | 2026-08-10 |